After Novartis and Walgreens, Qualcomm Life has scored another strategic partner for its 2net Platform. This time round it’s Roche which will use it to improve remote monitoring and management of chronic disease patients. Together, the two parties aim to advance chronic care management using connected therapy to further improve therapy quality, increase convenience and drive patient engagement in managing their health.
The 2net Platform will be used to seamlessly capture data from a patient’s medical devices, beginning with anticoagulation meters, and transmit it to Roche’s cloud-based back-end services. The 2net Platform provides an efficient way to exchange relevant health information between chronic disease patients and their care team or clinic to enable reduced therapy complications and total cost of care.
Connected chronic care management and remote management solutions can enhance patient care, enabling providers to asynchronously communicate with their patients in a high-tech model minimizing risk of errors in result reporting.
“By combining Qualcomm Life’s leadership in powering connected health solutions with our point-of-care expertise, we are taking an important step forward to realize our connected care strategy; ultimately enabling physicians to improve the overall quality of life for patients,” says Jeremy Moss, senior vice president, Point of Care at Roche Professional Diagnostics.